Physician Pay After a Private Equity Acquisition: What Typically Changes and Why

Private equity is now a common employer type in physician practice

Physician employment has become increasingly consolidated over the past decade. Hospital systems absorbed many formerly independent practices, and private equity-backed management companies expanded aggressively into specialties where practice revenues could be grown and later sold at a multiple. By 2022, the AMA's Physician Practice Benchmark Survey found that approximately 4.5% of physicians worked in practices owned by a private equity firm — a share that, while modest in absolute terms, represents a meaningful shift from virtually zero just a decade earlier and continues to grow in several high-volume specialties including dermatology, orthopedics, ophthalmology, gastroenterology, and urgent care.

For the physician already employed when an acquisition closes, the practical question is straightforward: what is about to change? The contract you signed — the one that established your base salary, your dollar-per-wRVU rate, your productivity threshold, your noncompete — may or may not survive the transaction intact. Understanding the typical dynamics of PE-backed compensation helps you ask the right questions before you sign anything new.

Why pay structures tend to shift after an acquisition

Private equity investors buy physician practices expecting to earn a return on that investment, usually within a three-to-seven year hold period, through a combination of revenue growth, margin improvement, and an eventual resale at a higher multiple. Physician compensation is typically the largest line item on the income statement of any medical practice. That creates a structural incentive — not a certainty, but a predictable force — to reduce the guaranteed component of physician pay and increase the portion that is tied to production.

This is not inherently exploitative; production-based pay aligns incentives in some respects. But the direction of the shift matters practically for a physician evaluating a new offer. A model that previously paid a reliable salary regardless of month-to-month volume variation now may pay a lower base with a meaningful variable component. The variable component is typically tied to wRVU production above a threshold, to net collections, or to some combination. The physician's total annual income may be comparable to the pre-acquisition model in an average production year — but the volatility around that average, and the floor in a low-volume stretch, are different propositions.

Timing matters too. PE acquirers often maintain the existing compensation structure for a defined transition period — commonly one to two years — to retain the physician workforce during integration. Physicians who do not carefully read the post-transition terms may not realize how significantly their pay model will change when the guarantee period expires.

The base salary and the guarantee period

In PE-backed employment structures, the "guarantee period" is the defined window during which the employer commits to pay at least a specified salary floor, independent of actual production. After that window closes, the full production formula takes over. Understanding the guarantee period is one of the highest-stakes items in any post-acquisition employment review.

When evaluating the new offer, confirm:

• Exactly when the guarantee ends. The end date should be a calendar date, not a formula tied to milestones or the employer's discretion. "Up to two years" is not the same as "through December 31 of your second contract year."
• What the post-guarantee formula is. The new contract should specify the base salary (if any), the dollar-per-wRVU rate, the production threshold above which the variable component is earned, and the measurement period. These terms should be in the four corners of the employment agreement — not in a separately attached policy document that the employer can update without your consent.
• Whether the threshold changes at guarantee end. Some contracts set a lower threshold during the guarantee period and a higher threshold after. If the post-guarantee threshold is materially above your typical production, the variable component will rarely trigger.
• Whether the base salary in the post-guarantee period is a true base or an advance against production. A recoverable draw is not a salary. If the contract describes a "draw" rather than a "salary," shortfalls accumulate as a balance you owe, not just forgone bonus. This distinction is covered in more detail in the guide on draw structures and threshold shortfalls.

Production thresholds and wRVU rates in PE-backed groups

The core economics of a wRVU-based productivity contract are simple: you earn a variable payment for each work RVU you generate above a set threshold. But the threshold and the per-wRVU rate can be set at any level the employer and physician agree to, and both are independently negotiable.

A production threshold set at the median of your specialty's MGMA benchmark sounds reasonable on paper, but the right comparison is not abstract — it is whether you can realistically produce at or above that level given the patient panel, schedule, staffing, and facility mix that your specific role entails. A threshold calibrated for a full outpatient volume may not be achievable in a hybrid inpatient/outpatient model, or in a setting where you are expected to carry significant non-billable administrative or teaching duties.

On the $/wRVU rate, the key distinction is between the employer's negotiated pay rate and the Medicare conversion factor. The CMS physician fee schedule sets how much Medicare pays for each RVU of billed work — approximately $32.35 in 2026 — but this is a billing rate, not a physician pay rate. Your employer's dollar-per-wRVU pay rate is a separately negotiated figure that varies by specialty, employer type, and local market conditions. PE-backed groups set their rates through internal analysis and market survey data; the rate you see in a PE offer may be higher or lower than what a hospital-employed colleague in the same specialty earns. The guide on how employer type affects $/wRVU rates covers the structural reasons these figures vary across settings.

Two additional threshold mechanics appear more frequently in PE-structured contracts than in traditional hospital employment:

• Tiered wRVU rates: Different dollar-per-wRVU amounts apply at different production bands — for example, a lower rate below the median, a higher rate above it. Whether tiers benefit or harm you depends entirely on where your production typically falls. The guide on tiered wRVU rate structures explains how these work in detail.
• Threshold ratchets: The productivity minimum increases annually, sometimes automatically tied to MGMA data or to a prior-year production average. This mechanism can erode the effective variable bonus over time even if the per-wRVU rate holds steady. The guide on wRVU threshold escalation covers how to identify and limit these clauses.

Noncompetes, termination rights, and exit protections

Compensation structure is only one dimension of what changes when PE acquires your practice. The exit terms — what you keep and what you owe if the relationship does not work — deserve equal scrutiny.

Noncompetes under PE ownership tend to be more aggressively drawn. When the acquirer is a regional or national platform company, the entity protected by the noncompete restriction is now larger than the one that originally employed you. Depending on the drafting, a two-year radius restriction that was limited to your single-site practice may now, in theory, protect a multi-state network. Enforceability is a state-law question — some states substantially limit or prohibit physician noncompetes by statute — but even a potentially unenforceable clause creates litigation risk and leverage. The guide on physician noncompete clauses discusses enforceability and negotiation approaches by jurisdiction type.

Without-cause termination windows in PE contracts can be short. The employer's right to terminate without cause on thirty to sixty days' notice is meaningfully different from a ninety-day or one-hundred-twenty-day window that gives a physician time to arrange alternative employment before income stops. Confirm the notice period runs both directions — that you can also exit on the same notice — and that the notice period is long enough to be practically useful.

Malpractice tail coverage terms need fresh review. If you were previously employed by an independent practice that carried occurrence coverage, or a hospital that self-insured, the PE acquirer may carry claims-made coverage with a different tail obligation structure. Who pays the tail if you leave — under any departure scenario — should be explicit in the new agreement. The claims-made vs. occurrence guide covers how these policies work and why the distinction matters for departing physicians.

Change-of-control rights may not survive into the PE offer. If your original contract had any change-of-control exit right — giving you the ability to treat the acquisition as an employer-initiated without-cause termination — that right was a single-use protection tied to the first transaction. The new employment agreement you are asked to sign after a PE acquisition is a fresh contract; it may or may not include a comparable protection. This is the moment to negotiate one. The guide on assignment and change-of-control clauses explains what these provisions cover and what protective language to ask for.

Questions to answer before you sign the new offer

A post-acquisition new employment agreement deserves as much careful review as the original contract — more, arguably, because the leverage dynamics are less favorable once you are already integrated into the practice's patient care workflow. These are the core questions to resolve:

• Is the full compensation formula in the contract itself, or does it reference a separate policy document? If the pay terms live in a referenced document that the employer can update unilaterally, you do not have a fixed-rate contract regardless of what the headline $/wRVU number suggests. Ask for all compensation-determining terms to be embedded in the agreement.
• What is the guarantee period end date, and what is the post-guarantee structure? Run the math on your expected production under the post-guarantee formula — using a realistic production estimate for the specific role, not a hypothetical maximum — before you commit to the contract.
• Is the base salary a guaranteed salary or a recoverable draw? The word "draw" signals a repayment obligation. Confirm the repayment mechanics and whether the draw balance survives termination.
• Does the threshold update annually, and by what mechanism? An auto-updating threshold can quietly reduce your effective bonus even if the rate stays constant.
• What are the noncompete terms, and what state's law governs? The enforceability analysis applies to the new contract's terms, not the old one. If the restriction has widened because the acquirer is a larger entity, the negotiation should reflect that change.
• Who pays malpractice tail under each departure scenario? Confirm this for voluntary resignation, without-cause employer termination, for-cause termination, and for a future change-of-control event.
• What happens to your signing bonus, relocation allowance, or income guarantee if you leave before vesting? Clawback triggers should be listed and understood before you accept any upfront payment tied to the new agreement.

None of these questions is adversarial in spirit. An employer confident in its offer should be willing to answer all of them clearly. Any significant resistance to embedding the compensation formula in the contract document itself, or to specifying a reasonable without-cause notice window, is worth treating as a data point about what the ongoing employment relationship will look like.